Page last updated: 2024-09-05

sorafenib and cl 387785

sorafenib has been researched along with cl 387785 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(cl 387785)
Trials
(cl 387785)
Recent Studies (post-2010) (cl 387785)
6,5207305,25134014

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)cl 387785 (IC50)
Proto-oncogene tyrosine-protein kinase SrcGallus gallus (chicken)0.001
Epidermal growth factor receptorHomo sapiens (human)0.0456
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)0.1952
Receptor tyrosine-protein kinase erbB-4Homo sapiens (human)0.012
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archibald, H; Dowell, L; Drew, L; Erlander, MG; Gray, NS; Greninger, P; Haber, DA; Hanke, JH; Iafrate, AJ; Lamb, J; Lee, D; Ma, XJ; Maheswaran, S; McDermott, U; Montagut, C; Njauw, CN; Raudales, R; Rothenberg, SM; Settleman, J; Sharma, SV; Sordella, R; Supko, JG; Tam, A; Tsao, H; Ulkus, LE1

Other Studies

1 other study(ies) available for sorafenib and cl 387785

ArticleYear
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-11, Volume: 104, Issue:50

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genotype; Humans; Neoplasms; Protein Kinase Inhibitors

2007